TSVT - 2seventy bio GAAP EPS of -$2.02 misses by $0.09 revenue of $13.48M misses by $3.04M
- 2seventy bio press release ( NASDAQ: TSVT ): Q2 GAAP EPS of -$2.02 misses by $0.09 .
- Revenue of $13.48M (+83.9% Y/Y) misses by $3.04M .
- Ended quarter with $399M cash, cash equivalents, and marketable securities; revising 2022 net cash spend to $245-265M; maintaining cash runway into 2025
- Shares +6% PM.
For further details see:
2seventy bio GAAP EPS of -$2.02 misses by $0.09, revenue of $13.48M misses by $3.04M